RAPID COMMUNICATION Xp22.2-3 Loss of Heterozygosity Is Associated with Germline BRCA1 Mutation in Ovarian Cancer 1

[1]  R. Buller,et al.  BRCA1 mutations in familial ovarian cancer. , 1999, Molecular genetics and metabolism.

[2]  D. Livingston,et al.  BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. , 1999, Cancer research.

[3]  A. Sood,et al.  Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer. , 1999, Journal of the National Cancer Institute.

[4]  R. Buller,et al.  The prognostic significance of X chromosome inactivation in ovarian carcinoma , 1999 .

[5]  Keith D Wilkinson,et al.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression , 1998, Oncogene.

[6]  Hongbing Zhang,et al.  BRCA1, BRCA2, and DNA Damage Response: Collision or Collusion? , 1998, Cell.

[7]  M. Edelson,et al.  A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors , 1998, Oncogene.

[8]  A. Berchuck,et al.  Loss of heterozygosity at chromosome segment Xq25‐26.1 in advanced human ovarian carcinomas , 1997, Genes, chromosomes & cancer.

[9]  R. Mazzarella,et al.  X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content. , 1997, Genome research.

[10]  A. Sood,et al.  Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reaction. , 1996, Oncogene.

[11]  R. Buller,et al.  p53 allelotypes and enhanced detection of allelic loss in ovarian cancer: lack of correlation with familial and clinical factors. , 1996, Gynecologic oncology.

[12]  R. Buller,et al.  Absence of significant germ line p53 mutations in ovarian cancer patients. , 1995, Gynecologic oncology.

[13]  R. Osborne,et al.  Polymerase chain reaction allelotyping of human ovarian cancer. , 1994, British Journal of Cancer.

[14]  M. Carcangiu,et al.  Allelic loss in ovarian cancer , 1993, International journal of cancer.

[15]  Shibo Li,et al.  Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer , 1992, International journal of cancer.

[16]  W. Brown,et al.  Detection of full fragile X mutation , 1992, The Lancet.

[17]  H. Willard,et al.  Localization of a gene that escapes inactivation to the X chromosome proximal short arm: implications for X inactivation. , 1990, American journal of human genetics.